Why are the Kidneys an Attractive Target for Coronavirus?

kidney cancer

Although the lungs are a common target for COVID-19’s cytokine storm, so are the kidneys, making the 1-in-4 U.S. adults with diabetes resulting in diabetic kidney disease at increased risk for virus mortality. But why are the kidneys so attractive to the coronavirus? Recently published in Kidney International, a nationalRead …

Read moreWhy are the Kidneys an Attractive Target for Coronavirus?

Rapid, Non-Invasive Liver Exam at Point of Care Improves Patient Outcomes

By Scott Howell, D.O., MPH&TM, CPE, Advisor to Echosens Physician practices providing integrative medicine (IM) understand the value of healing-oriented medicine that treats the whole person, including all aspects of patient lifestyles. The emphasis of the therapeutic relationship between practitioner and patient is informed by evidence and utilizes every appropriate therapy to meetRead …

Read moreRapid, Non-Invasive Liver Exam at Point of Care Improves Patient Outcomes

Intermittent Fasting Changes Liver Enzymes

liver enzymes and disease

Researchers in Australia have used state-of-the-art analytical tools to understand how intermittent fasting works on liver enzymes to help prevent disease. The findings will help medical scientists working in cancer, cardiovascular and diabetes research develop new interventions to lower disease risk and discover the optimum intervals for fasting. In experimentsRead …

Read moreIntermittent Fasting Changes Liver Enzymes

Echosens Aligns with Fatty Liver Foundation to Accelerate Screening for Undiagnosed Nonalcoholic Fatty Liver Disease

fatty liver

Echosens, a high-technology company offering the FibroScan family of products, is proud to support the Fatty Liver Foundation (FLF), a non-profit organization dedicated to fighting fatty liver disease and advocating for ongoing screening of undiagnosed nonalcoholic fatty liver disease (NAFLD) and its more severe form nonalcoholic steatohepatitis (NASH). FLF isRead …

Read moreEchosens Aligns with Fatty Liver Foundation to Accelerate Screening for Undiagnosed Nonalcoholic Fatty Liver Disease

Barrie Tan, PhD: Using Tocotrienols to Address Lifestyle and Metabolic Disease

In this interview from Dick Benson and Barrie Tan, PhD, from our partners at Integrative Medicine, a Clinician’s Journal, the two discuss the potential for tocotrienols to address non-alcoholic fatty liver disease and other metabolic health issues. See below for an excerpt of the interview and an opportunity to download

Read moreBarrie Tan, PhD: Using Tocotrienols to Address Lifestyle and Metabolic Disease

Non-alcoholic Fatty Liver Disease on the Rise, Moderate Exercise is a Viable Solution

liver enzymes and disease

The annual Digestive Disease Week, sponsored by the American Association for the Study of Liver Diseases, American Gastroenterological Association, American Society for Gastrointestinal Endoscopy, and Society for Surgery of the Alimentary Tract, was held from May 18 to 21 in San Diego. Two studies caught the attention of Today’s Practitioner:Read …

Read moreNon-alcoholic Fatty Liver Disease on the Rise, Moderate Exercise is a Viable Solution

Premature Birth Increases Risk of Chronic Kidney Disease from Childhood to Adulthood

kidney cancer

Preterm and early term birth are strong risk factors for the development of chronic kidney disease (CKD) from childhood into mid-adulthood, suggests a study from Sweden published by The BMJ. Given the high levels of preterm birth (currently 10% in the US and 5-8% in Europe), and better survival intoRead …

Read morePremature Birth Increases Risk of Chronic Kidney Disease from Childhood to Adulthood